Search
for
Sort by
Research 661–690 of 1000+
- Endocrine evaluation of hirsutism
- Evidence-based approach to cutaneous hyperandrogenism in women
- The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives
- Hair Growth Booster Effects of Micro-Needling with Low-Level Led Therapy and Growth Factors on Subjects Treated with Finasteride®
- Fissistigma oldhamii (Hemsl.) Merr.: Ethnomedicinal, Phytochemistry, and Pharmacological Aspects
- Nanomaterials in hair care and treatment
- Proteins in Scalp Hair of Preschool Children
- MECHANISM OF ACTION OF AVICENNIA MARINA HEARTWOOD EXTRACT AND AVICEQUINONE C ON HUMAN DERMAL PAPILLA CELLS ISOLATED FROM ANDROGENIC ALOPECIA PATIENTS
- Oxidative stress management in the hair follicle: Could targeting NRF2 counter age‐related hair disorders and beyond?
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- mRNA Levels of Aromatase, 5α-Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia
- Virtual Insights into Natural Compounds as Potential 5α-Reductase Type II Inhibitors: A Structure-Based Screening and Molecular Dynamics Simulation Study
- Androgenetic Alopecia
- Phytochemical Constitution, Anti-Inflammation, Anti-Androgen, and Hair Growth-Promoting Potential of Shallot (Allium ascalonicum L.) Extract
- Mechanistic synergy of hair growth promotion by the Avicennia marina extract and its active constituent (avicequinone C) in dermal papilla cells isolated from androgenic alopecia patients
- Possibilities and Limitations for Reversal of Age-Related Hair Loss
- Potential use of the Asteraceae family as a cure for diabetes: A review of ethnopharmacology to modern day drug and nutraceuticals developments
- Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study
- The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- Finasteride and androgenic alopecia; from therapeutic options to medical implications
- Effects of 5-alpha reductase inhibitors
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Addressing Androgenetic Alopecia-A Complex Disorder-with a Multilateral Treatment Strategy
- Comparative Studies on Polyamine Levels in Plasma and Urine of Androgenic Alopecia Patients Treated with Finasteride for a Period of Three Years
- 5-Alpha reductase deficiency
- Clinical biochemistry of dihydrotestosterone
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- What do we know about phytotherapy of benign prostatic hyperplasia?